Both in Pharmaceuticals
Cadrenal Therapeutics vs Apimeds Pharmaceuticals US
Over the past year CVKD returned −92.7% and APUS returned −87.9%; their daily moves had a correlation of 0.04.
CVKD −92.7% APUS −87.9%Growth of $1, one year, split-adjusted
| Metric | CVKD | APUS |
|---|---|---|
| Price | $0.9850 | $3.01 |
| Market cap | $3.5M | $4.5M |
| Today | +4.41% | −6.23% |
| 1 month | +1.5% | −26.6% |
| 6 months | −84.5% | — |
| Year to date | −85.5% | −81.6% |
| 1 year | −92.3% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $2.4M | -$8.6M |
| Dividend yield | — | — |
| Volatility (60d) | 87.2% | 265.1% |
| Short % of float | 9.2% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).